Tuberculosis remains one of the most dangerous infectious diseases worldwide. Our primary focus is on researching the immune response during infection and disease caused by Mycobacterium tuberculosis. We employ a wide range of different biological read outs to better comprehend the molecular mechanisms of infection and disease. Our objective is to develop new diagnostic methods and antibiotic‐independent host‐directed therapeutic strategies.